Abstract: Systems and methods for prosthetic device control with a unified virtual constraint that controls an entire gait cycle of the prosthetic device.

Abstract: Bacteria with tumor-targeting capability express, surface displayed, secreted and/or released modified chimeric therapeutic proteins with enhanced therapeutic activity against a neoplastic tissue including solid tumors, lymphomas and leukemias. The bacteria may be attenuated, non-pathogenic, low pathogenic or a probiotic. The chimeric proteins may be protease sensitive and may optionally be further accompanied by co-expression of a secreted protease inhibitor as a separate molecule or as a fusion.

Abstract: A magnetic necklace mount for a camera or mobile device is described. A magnetic necklace pendant for a camera or mobile device that allows the user the ability to attach, break-a-way and re-attach the device magnetically. The magnetic necklace holder includes a pendant of any shape with a cavity formed from an inject-able material which houses a magnet. The magnetic pendant attaches to the device by an accompanying plate that is of ferromagnetic material that includes a double sided adhesive pad that is attached to the camera or mobile device.

Abstract: Systems and methods for prosthetic device control with a unified virtual constraint that controls an entire gait cycle of the prosthetic device.

Abstract: The present invention provides purified protease inhibitors derived from microorganisms alone or in combination with bacteriocins and/or antibodies. The protease inhibitors may also be expressed by microbiome or probiotic microorganisms alone or in combination with bacteriocins and/or antibodies. The invention also provides methods and compositions for improving the expression of endogenous or heterologous protease inhibitors alone or in combination with bacteriocins and/or antibodies. The invention is useful for treating a variety of inflammatory disorders including acne, psoriasis, eczema, atopic dermatitis and inflammatory bowel disease.

Abstract: Bacteria with tumor-targeting capability express, surface displayed, secreted and/or released modified chimeric therapeutic proteins with enhanced therapeutic activity against a neoplastic tissue including solid tumors, lymphomas and leukemias. The bacteria may be attenuated, non-pathogenic, low pathogenic or a probiotic. The chimeric proteins may be protease sensitive and may optionally be further accompanied by co-expression of a secreted protease inhibitor as a separate molecule or as a fusion.